GOVERNEUR, N.Y. – Kinney Drugs has now opened both walk-ins and appointments for a second dose of seasonal COVID-19 vaccine for eligible individuals. In October, the CDC recommended that individuals aged 65 and older and those who are moderately to severely immunocompromised receive a second dose of seasonal COVID-19 vaccine two to six months after their last dose.
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose. Kinney Drugs accepts walk-ins; however, appointments are encouraged to ensure the promptest service. The COVID-19 vaccine can be co-administered with all other approved vaccines.
“CDC data show the importance of vaccination to protect people who are most at risk for severe outcomes of COVID, such as older adults and anyone with an immunocompromising condition,” said John Marraffa, president of Kinney Drugs. “We know that vaccination can restore and enhance protection against those viruses that are causing infections and hospitalizations in our region, including RSV, COVID, and influenza. And flu is spiking right now, especially in older populations. So, if patients haven’t received their flu vaccine, it’s not too late for this year. As always, our pharmacists stand ready to assist with immunizations and other healthcare needs,” he added.
Kinney Drugs expands COVID-19 vaccine access for high-risk individuals
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose.

Latest

Vital Proteins unveils ready-to-drink protein shake featuring collagen
The Vital Proteins Collagen & Protein Shake is the brand's first-ever ready-to-drink protein shake offering.

Zebra Technologies buys Elo to accelerate connected frontline experiences
The combined business will empower retailers and QSRs to elevate consumer experiences within the AI-powered Modern Store.

ProRx Pharma highlights role of 503B compounders in personalized care during National Wellness Month
"Wellness is more than a buzzword—it's a responsibility," said Kurt Lunkwitz, chief operations officer at ProRx.

Alcon to acquire STAAR Surgical
STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes.